Dry Eye Syndrome Treatment - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Segmented by Indication (Evaporative Dry Eye Syndrome v/s Aqueous Deficient Dry Eye Syndrome), By Product Type (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, and Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and Ointments), By Type (Prescription v/s Over The Counter), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, and Competition

Published	Pages	Publisher	Report code
Apr 2023	111	TechSci Research	ASDR-619537

Published: Apr 2023 - Pages : 111 - Publisher : TechSci Research - Report code : ASDR-619537

1.Johnson & Johnson
2.AbbVie Inc.
3.Bausch Health Companies Inc.
4.Novartis AG
5.Sun Pharmaceuticals Industries Limited
6.Santen Pharmaceutical Co. Ltd.
7.Otsuka Pharmaceutical Co. Ltd.
8.Oyster Point Pharma Inc.
9.Alcon Inc.
10.GlaxoSmithKline plc.

Global Dry Eye Syndrome Market - 2024-2031

This report can be of interest as well:

Global Dry Eye Syndrome Market - 2024-2031

Published: March, 2025 | Report code: ASDR-674541